{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:57Z","timestamp":1787017077012,"version":"build-2736575974"},"reference-count":154,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2025,6,13]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Patients hospitalized for headache treatment pose unique challenges to the healthcare system. Currently, there is a lack of evidence-based guidance on management. This practice advisory aims to fill this critical gap by systematically reviewing the existing literature and providing comprehensive, evidence-based recommendations for managing headache patients during hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In February 2023, the American Society of Regional Anesthesia and Pain Medicine approved this practice advisory proposal. The steering committee selected committee members based on clinical and research expertise in the field of headache medicine. Nine questions were formulated by the committee, and each question was assigned to a group composed of 3\u20134 members. A systematic literature search for each question was performed in Medline, Embase, Cochrane Database of Systematic Reviews and Web of Science on June 21, 2023. The results from each search were imported into separate Covidence projects for screening, data extraction, and risk of bias assessment. Additionally, relevant systematic reviews (SR) were screened. Each group submitted a structured narrative review along with statements and recommendations based on the US Preventive Services Task Force (USPSTF) format for grading of evidence. While the USPSTF framework was used, including the language in the recommendations, the formal USPSTF methodology, including the SR with meta-analysis and summary tables with forest plots, was not followed because of low overall evidence quality. The interim draft was shared electronically with each collaborator, who was requested to vote anonymously using two rounds of the modified Delphi approach. A consensus recommendation required &gt;75% agreement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The panel generated 12 statements and 17 recommendations, along with their strength and certainty of evidence. Following two rounds of Delphi voting, a high consensus was achieved for all statements and recommendations. Most statements received a low-to-moderate level of certainty, and all but one recommendation received grade B or C, which was consistent with the lack of randomized controlled trials supporting most of the drugs in this document.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This evidence-based practice advisory provides a foundational step toward standardizing inpatient headache care and highlights existing gaps in the literature that should be addressed through rigorous prospective randomized studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rapm-2025-106718","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:00:15Z","timestamp":1751457615000},"page":"117-131","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Practice advisory for intravenous management of headache disorders in hospitalized patients: a review of the evidence and consensus recommendations"],"prefix":"10.1136","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0893-8813","authenticated-orcid":false,"given":"Yasmine","family":"Hoydonckx","sequence":"first","affiliation":[{"name":"Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Feoktistov","sequence":"additional","affiliation":[{"name":"Synergy Integrative Headache Center, Northfield, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Amoozegar","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"Anderson","sequence":"additional","affiliation":[{"name":"Neurology and Pain Management, Ochsner Health Center, Covington, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Barad","sequence":"additional","affiliation":[{"name":"Anesthesiology, Perioperative and Pain Medicine, Stanford Hospital and Clinics, Redwood, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeralda","family":"Burke","sequence":"additional","affiliation":[{"name":"Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prin","family":"Chitsantikul","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5011-3298","authenticated-orcid":false,"given":"Tina L","family":"Doshi","sequence":"additional","affiliation":[{"name":"Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2199-1056","authenticated-orcid":false,"given":"Marina","family":"Englesakis","sequence":"additional","affiliation":[{"name":"Library & Information Services, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Goel","sequence":"additional","affiliation":[{"name":"Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Gupta","sequence":"additional","affiliation":[{"name":"Neurology, University of Toronto , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan","family":"Kissoon","sequence":"additional","affiliation":[{"name":"Neurology & Anesthesiology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Kirschner","sequence":"additional","affiliation":[{"name":"Neurology, University of Toronto , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0407-806X","authenticated-orcid":false,"given":"Lynn","family":"Kohan","sequence":"additional","affiliation":[{"name":"Anesthesiology, University of Virginia School of Medicine, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton G","family":"Lauritsen","sequence":"additional","affiliation":[{"name":"Jefferson Headache Center -Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Miller","sequence":"additional","affiliation":[{"name":"Anesthesiology, Perioperative and Pain Medicine, Stanford Hospital and Clinics, Redwood, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Monsour","sequence":"additional","affiliation":[{"name":"Neurology, University of Toronto , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-5507","authenticated-orcid":false,"given":"Antoun","family":"Nader","sequence":"additional","affiliation":[{"name":"Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyindamola","family":"Ogunlaja","sequence":"additional","affiliation":[{"name":"Anesthesiology, Perioperative and Pain Medicine, Stanford Hospital and Clinics, Redwood, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Schuster","sequence":"additional","affiliation":[{"name":"Anesthesiology, UC San Diego Health, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3464-4149","authenticated-orcid":false,"given":"Eric S","family":"Schwenk","sequence":"additional","affiliation":[{"name":"Anesthesiology and Perioperative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D","family":"Silberstein","sequence":"additional","affiliation":[{"name":"Jefferson Headache Center -Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Souza","sequence":"additional","affiliation":[{"name":"Pain Medicine, Western Reserve Hospital Partners, Cuyahoga Falls, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-9974","authenticated-orcid":false,"given":"Hsiangkuo","family":"Yuan","sequence":"additional","affiliation":[{"name":"Jefferson Headache Center -Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Narouze","sequence":"additional","affiliation":[{"name":"Anesthesiology, Case Western Reserve University, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"2026020508450743000_51.2.117.1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14024"},{"key":"2026020508450743000_51.2.117.2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000965"},{"key":"2026020508450743000_51.2.117.3","doi-asserted-by":"publisher","DOI":"10.1177\/0333102411425960"},{"key":"2026020508450743000_51.2.117.4","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-020-01030-w","article-title":"Emergency Department and Inpatient Management of Headache in Adults","volume":"20","author":"Robblee","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2026020508450743000_51.2.117.5","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-015-0531-y","article-title":"Update of Inpatient Treatment for Refractory Chronic Daily Headache","volume":"20","author":"Lai","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"2026020508450743000_51.2.117.6","doi-asserted-by":"publisher","DOI":"10.1111\/head.14541"},{"key":"2026020508450743000_51.2.117.7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1177\/0333102419847973","article-title":"Neurology residents\u2019 knowledge of the management of headache","volume":"39","author":"Kristoffersen","year":"2019","journal-title":"Cephalalgia"},{"key":"2026020508450743000_51.2.117.8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1526-4610.2005.05155.x","article-title":"Headache in Medical Education: Medical Schools, Neurology and Family Practice Residencies","volume":"45","author":"Gallagher","year":"2005","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.9","unstructured":"USPSTF . Grade definitions after 2012. 2025. Available: www.uspreventiveservicestaskforce.org\/uspstf\/about- uspstf\/methods-and-processes\/grade-definitions#july2012"},{"key":"2026020508450743000_51.2.117.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.12.002"},{"key":"2026020508450743000_51.2.117.11","doi-asserted-by":"publisher","DOI":"10.1177\/1937586719887709"},{"key":"2026020508450743000_51.2.117.12","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2024-105280"},{"key":"2026020508450743000_51.2.117.13","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2022-104013"},{"key":"2026020508450743000_51.2.117.14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/head.13700","article-title":"Dihydroergotamine (DHE) \u2013 Then and Now: A Narrative Review","volume":"60","author":"Silberstein","year":"2020","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(00)00010-1"},{"key":"2026020508450743000_51.2.117.16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1991.1104165.x"},{"key":"2026020508450743000_51.2.117.17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/119.1.249","article-title":"Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine","volume":"119","author":"Hoskin","year":"1996","journal-title":"Brain (Bacau)"},{"key":"2026020508450743000_51.2.117.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1988.0802083.x"},{"key":"2026020508450743000_51.2.117.19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/17425250903164211","article-title":"Dihydroergotamine: role in the treatment of migraine","volume":"5","author":"Sch\u00fcrks","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2026020508450743000_51.2.117.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1990.hed3006334.x"},{"key":"2026020508450743000_51.2.117.21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1017\/S031716710003376X","article-title":"In-Patient Treatment of Chronic Daily Headache Using Dihydroergotamine: a Long-term Follow-up Study","volume":"25","author":"Pringsheim","year":"1998","journal-title":"Can j neurol sci"},{"key":"2026020508450743000_51.2.117.22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1526-4610.1997.3703129.x","article-title":"Continuous intravenous dihydroergotamine in the treatment of intractable headache","volume":"37","author":"Ford","year":"1997","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.23","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-005-0077-5"},{"key":"2026020508450743000_51.2.117.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1991.hed3110658.x"},{"key":"2026020508450743000_51.2.117.25","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0b013e3182377dbb","article-title":"Intravenous dihydroergotamine for inpatient management of refractory primary headaches","volume":"77","author":"Nagy","year":"2011","journal-title":"Neurology (ECronicon)"},{"key":"2026020508450743000_51.2.117.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1992.hed3209439.x"},{"key":"2026020508450743000_51.2.117.27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.36.7.995","article-title":"Repetitive intravenous dihydroergotamine as therapy for intractable migraine","volume":"36","author":"Raskin","year":"1986","journal-title":"Neurology (ECronicon)"},{"key":"2026020508450743000_51.2.117.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1991.hed3108525.x"},{"key":"2026020508450743000_51.2.117.29","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415570495"},{"key":"2026020508450743000_51.2.117.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(95)70001-3"},{"key":"2026020508450743000_51.2.117.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-6757(96)90171-0"},{"key":"2026020508450743000_51.2.117.32","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/head.12904","article-title":"Is the Generally Held View That Intravenous Dihydroergotamine Is Effective in Migraine Based on Wrong 'General Consensus' of One Trial? A Critical Review of the Trial and Subsequent Quotations","volume":"56","author":"Bekan","year":"2016","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1526-4610.1996.3605291.x","article-title":"Early and transient side effects of repetitive intravenous dihydroergotamine","volume":"36","author":"Queiroz","year":"1996","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.34","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1212\/WNL.0000000000002406","article-title":"Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome","volume":"86","author":"Eller","year":"2016","journal-title":"Neurology (ECronicon)"},{"key":"2026020508450743000_51.2.117.35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1212\/WNL.0000000000004108","article-title":"Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment","volume":"89","author":"Tso","year":"2017","journal-title":"Neurology (ECronicon)"},{"key":"2026020508450743000_51.2.117.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00840.x"},{"key":"2026020508450743000_51.2.117.37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1992.1201021.x"},{"key":"2026020508450743000_51.2.117.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1989.hed2907416.x"},{"key":"2026020508450743000_51.2.117.39","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.111006171.x"},{"key":"2026020508450743000_51.2.117.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2014.06.055"},{"key":"2026020508450743000_51.2.117.41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/PL00012190","article-title":"Efficacy of intravenous magnesium sulfate in severe migraine attacks","volume":"2","author":"Zidverc-Trajkovi\u0107","year":"2001","journal-title":"J Headache Pain"},{"key":"2026020508450743000_51.2.117.42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajem.2020.09.033","article-title":"MAGraine: Magnesium compared to conventional therapy for treatment of migraines","volume":"39","author":"Kandil","year":"2021","journal-title":"Am J Emerg Med"},{"key":"2026020508450743000_51.2.117.43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/cs0890633","article-title":"Intravenous Magnesium Sulphate Relieves Migraine Attacks in Patients with Low Serum Ionized Magnesium Levels: A Pilot Study","volume":"89","author":"Mauskop","year":"1995","journal-title":"Clin Sci"},{"key":"2026020508450743000_51.2.117.44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1996.3603154.x"},{"key":"2026020508450743000_51.2.117.45","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.119424"},{"key":"2026020508450743000_51.2.117.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(99)00220-6"},{"key":"2026020508450743000_51.2.117.47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00364.x"},{"key":"2026020508450743000_51.2.117.48","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2003.03170.x"},{"key":"2026020508450743000_51.2.117.49","first-page":"369","article-title":"Magnesium sulfate and acute migraine: A randomized clinical trial","volume":"11","author":"Motamed","year":"2020","journal-title":"Ann Clin Anal Med"},{"key":"2026020508450743000_51.2.117.50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/TME.0000000000000319","article-title":"Valproic Acid in the Treatment of Migraines","volume":"42","author":"Brown","year":"2020","journal-title":"Adv Emerg Nurs J"},{"key":"2026020508450743000_51.2.117.51","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153"},{"key":"2026020508450743000_51.2.117.52","doi-asserted-by":"publisher","DOI":"10.1111\/head.12835"},{"key":"2026020508450743000_51.2.117.53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/ane.13325","article-title":"Intravenous sodium valproate for acute migraine in the emergency department: A meta-analysis","volume":"142","author":"Wang","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"2026020508450743000_51.2.117.54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajem.2022.02.046","article-title":"Intravenous ibuprofen versus sodium valproate in acute migraine attacks in the emergency department: A randomized clinical trial","volume":"55","author":"Dogruyol","year":"2022","journal-title":"Am J Emerg Med"},{"key":"2026020508450743000_51.2.117.55","first-page":"171","article-title":"Comparison between Intravenous Sodium Valproate and Subcutaneous Sumatriptan for Treatment of Acute Migraine Attacks; Double-Blind Randomized Clinical Trial","volume":"39","author":"Rahimdel","year":"2014","journal-title":"Iran J Med Sci"},{"key":"2026020508450743000_51.2.117.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04010.x"},{"key":"2026020508450743000_51.2.117.57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2010.01394.x"},{"key":"2026020508450743000_51.2.117.58","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02127.x"},{"key":"2026020508450743000_51.2.117.59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/head.13756","article-title":"Retrospective Chart Review of Intravenous Valproate Sodium as a Preventive Treatment for Patients With Chronic Migraine","volume":"60","author":"Riggins","year":"2020","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40263-015-0304-5","article-title":"Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion","volume":"30","author":"Cook","year":"2016","journal-title":"CNS Drugs"},{"key":"2026020508450743000_51.2.117.61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40262-017-0553-1","article-title":"Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial","volume":"57","author":"Georgoff","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"2026020508450743000_51.2.117.62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05153.x"},{"key":"2026020508450743000_51.2.117.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.10.002"},{"key":"2026020508450743000_51.2.117.64","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/ph3061966","article-title":"NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data","volume":"3","author":"Pardutz","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026020508450743000_51.2.117.65","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/head.14307","article-title":"A randomized trial of ketorolac and metoclopramide for migraine in the emergency department","volume":"62","author":"Richer","year":"2022","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/papr.12198","article-title":"Ketorolac Tromethamine \u2013 Routes and Clinical Implications","volume":"15","author":"Vadivelu","year":"2015","journal-title":"Pain Pract"},{"key":"2026020508450743000_51.2.117.67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.1998.tb02463.x"},{"key":"2026020508450743000_51.2.117.68","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/acem.14457","article-title":"Efficacy of ketorolac in the treatment of acute migraine attack: A systematic review and meta\u2010analysis","volume":"29","author":"Nurathirah","year":"2022","journal-title":"Acad Emerg Med"},{"key":"2026020508450743000_51.2.117.69","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.0000000000000223","article-title":"Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine","volume":"82","author":"Friedman","year":"2014","journal-title":"Neurology (ECronicon)"},{"key":"2026020508450743000_51.2.117.70","first-page":"921","article-title":"Ketorolac, an injectable nonnarcotic analgesic","volume":"9","author":"Litvak","year":"1990","journal-title":"Clin Pharm"},{"key":"2026020508450743000_51.2.117.71","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4857","article-title":"Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study","volume":"354","author":"Arf\u00e8","year":"2016","journal-title":"BMJ"},{"key":"2026020508450743000_51.2.117.72","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530290046036"},{"key":"2026020508450743000_51.2.117.73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.annemergmed.2016.10.014","article-title":"Comparison of Intravenous Ketorolac at Three Single-Dose Regimens for Treating Acute Pain in the Emergency Department: A Randomized Controlled Trial","volume":"70","author":"Motov","year":"2017","journal-title":"Ann Emerg Med"},{"key":"2026020508450743000_51.2.117.74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","article-title":"The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache J Head Face Pain"},{"key":"2026020508450743000_51.2.117.75","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414566200"},{"key":"2026020508450743000_51.2.117.76","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2016.1140743"},{"key":"2026020508450743000_51.2.117.77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02748.x"},{"key":"2026020508450743000_51.2.117.78","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1111\/ene.15956","article-title":"European Academy of Neurology guidelines on the treatment of cluster headache","volume":"30","author":"May","year":"2023","journal-title":"Eur J Neurol"},{"key":"2026020508450743000_51.2.117.79","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1468-1331.2006.01566.x","article-title":"EFNS guidelines on the treatment of cluster headache and other trigeminal\u2010autonomic cephalalgias","volume":"13","author":"May","year":"2006","journal-title":"Euro J of Neurology"},{"key":"2026020508450743000_51.2.117.80","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10072-020-04675-0","article-title":"Drug withdrawal along with bridge therapy with methylprednisolone and\/or diazepam for treatment of medication overuse headache: a preliminary report from the WASH-OUT study","volume":"41","author":"Vernieri","year":"2020","journal-title":"Neurol Sci"},{"key":"2026020508450743000_51.2.117.81","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-005-0225-7"},{"key":"2026020508450743000_51.2.117.82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10072-010-0319-0","article-title":"The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline","volume":"31","author":"Valguarnera","year":"2010","journal-title":"Neurol Sci"},{"key":"2026020508450743000_51.2.117.83","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.01151.x"},{"key":"2026020508450743000_51.2.117.84","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s10072-012-1282-8","article-title":"Complete remission of SUNCT syndrome by intravenous glucocorticoid treatment","volume":"34","author":"Maih\u00f6fner","year":"2013","journal-title":"Neurol Sci"},{"key":"2026020508450743000_51.2.117.85","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/1874205X02014010074","article-title":"Short-Lasting Unilateral Neuralgiform Headache Attacks with Conjunctival Injection and Tearing (SUNCT) Status Like Condition: A Rare Case Report and Review of the Literature","volume":"14","author":"Gurumukhani","year":"2020","journal-title":"TONEUJ"},{"key":"2026020508450743000_51.2.117.86","doi-asserted-by":"crossref","DOI":"10.1186\/2193-1801-2-156","article-title":"High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache","volume":"2","author":"Kawada","year":"2013","journal-title":"Springerplus"},{"key":"2026020508450743000_51.2.117.87","first-page":"355","article-title":"High-Dose Intravenous Methylprednisolone Use for Transitional Prophylaxis in Drug - Resistant Cluster Headache","volume":"31","author":"Taktakoglu Ozdogru","year":"2014","journal-title":"J Neurol Sci Turk"},{"key":"2026020508450743000_51.2.117.88","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1526-4610.2008.01269.x","article-title":"Hemicrania continua responsive to intravenous methyl prednisolone","volume":"49","author":"Prakash","year":"2009","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.89","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/CON.0000000000001104","article-title":"Update on Antiseizure Medications 2022","volume":"28","author":"Abou-Khalil","year":"2022","journal-title":"Continuum (Mount Lawley)"},{"key":"2026020508450743000_51.2.117.90","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/CON.0000000000001103","article-title":"Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus","volume":"28","author":"Trinka","year":"2022","journal-title":"Continuum (Mount Lawley)"},{"key":"2026020508450743000_51.2.117.91","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph15040475","article-title":"Levetiracetam Mechanisms of Action: From Molecules to Systems","volume":"15","author":"Contreras-Garc\u00eda","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026020508450743000_51.2.117.92","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1358\/dot.2007.43.11.1136902","article-title":"Levetiracetam","volume":"43","author":"Carreno","year":"2007","journal-title":"Drugs Today"},{"key":"2026020508450743000_51.2.117.93","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.emc.2010.09.004","article-title":"Antiepileptic drugs: the old and the new","volume":"29","author":"Hung","year":"2011","journal-title":"Emerg Med Clin North Am"},{"key":"2026020508450743000_51.2.117.94","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-007-0378-7"},{"key":"2026020508450743000_51.2.117.95","first-page":"107","article-title":"Levetiracetam, given intravenously, for acute intractable migraines (Abstract)","volume":"9","author":"Krusz","year":"2002","journal-title":"Eur J Neurol"},{"key":"2026020508450743000_51.2.117.96","doi-asserted-by":"publisher","DOI":"10.1097\/01.WNF.0000236766.08409.03"},{"key":"2026020508450743000_51.2.117.97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jcpt.12715","article-title":"Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review","volume":"43","author":"Watkins","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"2026020508450743000_51.2.117.98","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jfma.2020.08.020","article-title":"Efficacy of levetiracetam for migraine prophylaxis: A systematic review and meta-analysis","volume":"120","author":"Yen","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"2026020508450743000_51.2.117.99","doi-asserted-by":"crossref","unstructured":"Medrea I , Cooper P , Langman M , et al . Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis. Can J Neurol Sci 2024;1\u201323. doi:10.1017\/cjn.2024.285","DOI":"10.1017\/cjn.2024.285"},{"key":"2026020508450743000_51.2.117.100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00586.x"},{"key":"2026020508450743000_51.2.117.101","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.151951"},{"key":"2026020508450743000_51.2.117.102","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/ejn.16106","article-title":"D2 dopamine receptor-mediated mechanisms of dopaminergic system modulation in in vivo and in vitro experimental models of migraine","volume":"59","author":"Baranoglu Kilinc","year":"2024","journal-title":"Eur J Neurosci"},{"key":"2026020508450743000_51.2.117.103","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/brain\/awac104","article-title":"Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine","volume":"145","author":"Watanabe","year":"2022","journal-title":"Brain (Bacau)"},{"key":"2026020508450743000_51.2.117.104","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/WNL.0000000000003861","article-title":"Dopamine D2\/D3 imbalance during migraine attack and allodynia in vivo","volume":"88","author":"DaSilva","year":"2017","journal-title":"Neurology (ECronicon)"},{"key":"2026020508450743000_51.2.117.105","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","article-title":"Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED]: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Silberstein","year":"2000","journal-title":"Neurology (ECronicon)"},{"key":"2026020508450743000_51.2.117.106","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12883-023-03259-7","article-title":"The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials","volume":"23","author":"Abdelmonem","year":"2023","journal-title":"BMC Neurol"},{"key":"2026020508450743000_51.2.117.107","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/head.13527","article-title":"The Efficacy and Safety of Prochlorperazine in Patients With Acute Migraine: A Systematic Review and Meta-Analysis","volume":"59","author":"Golikhatir","year":"2019","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.108","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/head.14091","article-title":"A prospective, randomized, double\u2010blind trial of intravenous chlorpromazine versus intravenous prochlorperazine for the treatment of acute migraine in adults presenting to the emergency department","volume":"61","author":"Hodgson","year":"2021","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.109","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.1995.tb03596.x"},{"key":"2026020508450743000_51.2.117.110","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(02)00502-4"},{"key":"2026020508450743000_51.2.117.111","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1590\/S0004-282X2002000400004","article-title":"Intravenous chlorpromazine in the acute treatment of episodic tension-type headache: a randomized, placebo controlled, double-blind study","volume":"60","author":"Bigal","year":"2002","journal-title":"Arq Neuro-Psiquiatr"},{"key":"2026020508450743000_51.2.117.112","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2001.tb01147.x"},{"key":"2026020508450743000_51.2.117.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2003.05.005"},{"key":"2026020508450743000_51.2.117.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2007.09.047"},{"key":"2026020508450743000_51.2.117.115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jemermed.2020.04.018","article-title":"Treatment of Headache in the Emergency Department: Haloperidol in the Acute Setting (THE-HA Study): A Randomized Clinical Trial","volume":"59","author":"McCoy","year":"2020","journal-title":"J Emerg Med"},{"key":"2026020508450743000_51.2.117.116","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jemermed.2015.03.023","article-title":"A Randomized Controlled Trial of Intravenous Haloperidol vs. Intravenous Metoclopramide for Acute Migraine Therapy in the Emergency Department","volume":"49","author":"Gaffigan","year":"2015","journal-title":"J Emerg Med"},{"key":"2026020508450743000_51.2.117.117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2008.03.044"},{"key":"2026020508450743000_51.2.117.118","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/1742-6723.12062","article-title":"Administration of metoclopramide by infusion or bolus does not affect the incidence of drug\u2010induced akathisia","volume":"25","author":"Egerton\u2010Warburton","year":"2013","journal-title":"Emerg Medicine Australasia"},{"key":"2026020508450743000_51.2.117.119","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(00)00297-3"},{"key":"2026020508450743000_51.2.117.120","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2004.014712"},{"key":"2026020508450743000_51.2.117.121","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2007.057570"},{"key":"2026020508450743000_51.2.117.122","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2017-206944"},{"key":"2026020508450743000_51.2.117.123","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1526-4610.2008.01281.x","article-title":"Intravenous lidocaine in the treatment of refractory headache: a retrospective case series","volume":"49","author":"Rosen","year":"2009","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.124","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/head.13298","article-title":"The Use and Method of Action of Intravenous Lidocaine and Its Metabolite in Headache Disorders","volume":"58","author":"Berk","year":"2018","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5694\/j.1326-5377.2000.tb125538.x","article-title":"Intravenous lignocaine infusions for severe chronic daily headache","volume":"172","author":"Hand","year":"2000","journal-title":"Med J Aust"},{"key":"2026020508450743000_51.2.117.126","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2021-103180"},{"key":"2026020508450743000_51.2.117.127","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1920"},{"key":"2026020508450743000_51.2.117.128","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.842082","article-title":"Intravenous Lidocaine and Ketamine Infusions for Headache Disorders: A Retrospective Cohort Study","volume":"13","author":"Ray","year":"2022","journal-title":"Front Neurol"},{"key":"2026020508450743000_51.2.117.129","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01800.x"},{"key":"2026020508450743000_51.2.117.130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1468-2982.2009.01871.x","article-title":"Response to Intravenous Lidocaine in a Patient with SUNCT Syndrome","volume":"30","author":"Arroyo","year":"2010","journal-title":"Cephalalgia"},{"key":"2026020508450743000_51.2.117.131","doi-asserted-by":"crossref","first-page":"251581631876882","DOI":"10.1177\/2515816318768827","article-title":"Termination of SUNCT with intravenous lignocaine followed by oral mexiletine","volume":"1","author":"Mulroy","year":"2018","journal-title":"Cephalalgia Reports"},{"key":"2026020508450743000_51.2.117.132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00886.x"},{"key":"2026020508450743000_51.2.117.133","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/head.13699","article-title":"IV Lidocaine Infusion Leading to the Toxic Levels in Serum Causing Asystole \u2013 A Case Report","volume":"60","author":"Digala","year":"2020","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.134","first-page":"251581631880481","article-title":"Dramatic response of intravenous lidocaine in a patient with status like SUNA: A case report and brief review of literature","volume":"1","author":"Chowdhury","year":"2018","journal-title":"Cephalalgia Rep"},{"key":"2026020508450743000_51.2.117.135","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323999"},{"key":"2026020508450743000_51.2.117.136","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1981.00340010039011"},{"key":"2026020508450743000_51.2.117.137","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000808"},{"key":"2026020508450743000_51.2.117.138","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2018.08.078"},{"key":"2026020508450743000_51.2.117.139","doi-asserted-by":"publisher","DOI":"10.1111\/head.13013"},{"key":"2026020508450743000_51.2.117.140","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000827"},{"key":"2026020508450743000_51.2.117.141","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","article-title":"A randomized controlled trial of intranasal ketamine in migraine with prolonged aura","volume":"80","author":"Afridi","year":"2013","journal-title":"Neurology (ECronicon)"},{"key":"2026020508450743000_51.2.117.142","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-016-0700-3","article-title":"Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series","volume":"17","author":"Lauritsen","year":"2016","journal-title":"J Headache Pain"},{"key":"2026020508450743000_51.2.117.143","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2019-101173"},{"key":"2026020508450743000_51.2.117.144","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.03.026"},{"key":"2026020508450743000_51.2.117.145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: risks and benefits","volume":"77","author":"Niesters","year":"2014","journal-title":"Brit J Clinical Pharma"},{"key":"2026020508450743000_51.2.117.146","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000416"},{"key":"2026020508450743000_51.2.117.147","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000707"},{"key":"2026020508450743000_51.2.117.148","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.09.036"},{"key":"2026020508450743000_51.2.117.149","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-8180(99)00131-2"},{"key":"2026020508450743000_51.2.117.150","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/ijnp\/pyx055","article-title":"Factors Influencing the Cardiovascular Response to Subanesthetic Ketamine: A Randomized, Placebo-Controlled Trial","volume":"20","author":"Liebe","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026020508450743000_51.2.117.151","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11739-019-02266-2","article-title":"Acute headache management in emergency department. A narrative review","volume":"15","author":"Giamberardino","year":"2020","journal-title":"Intern Emerg Med"},{"key":"2026020508450743000_51.2.117.152","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1526-4610.2012.02140.x","article-title":"Opioids Should Not Be Used in Migraine","volume":"52","author":"Tepper","year":"2012","journal-title":"Headache"},{"key":"2026020508450743000_51.2.117.153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2007.07.068"},{"key":"2026020508450743000_51.2.117.154","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1055\/s-0035-1564300","article-title":"Approach to the Workup and Management of Headache in the Emergency Department and Inpatient Settings","volume":"35","author":"Levin","year":"2015","journal-title":"Semin Neurol"}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2025-106718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:46:10Z","timestamp":1770309970000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2025-106718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":154,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,5]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/rapm-2025-106718"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2025-106718","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}